Adherium Limited (ASX.ADR) is an international Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers.
Adherium’s Hailie® sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and COPD, and reduce direct and indirect healthcare costs. Together with our strategic partners, we are developing new generation technology and working to deliver value to payers and providers, while maximizing the positive reimbursement environment with remote patient monitoring (RPM) payments now in place.
Adherium’s Hailie® digital solution comprises patented sensors and proprietary algorithms that track medication delivery, capturing data for clinicians and generating auditable reimbursement reports for payers and providers.
• Most clinical evidence of any digital respiratory monitor (>85 studies involving 13,000 patients)
• Clinically proven to improve adherence and outcomes
• >170,000 devices sold in 30 countries
• Widest US inhaler market coverage
• Funded technology upgrade will access US reimbursement
Location: New Zealand, Auckland
Employees: 11-50
Total raised: $3M
Founded date: 2001
Investors 4
Date | Name | Website |
- | New Zealan... | nzgcp.co.n... |
- | Bioscience... | bioscience... |
- | Cure Kids ... | curekidsve... |
- | Icehouse V... | icehouseve... |
Funding Rounds 1
Date | Series | Amount | Investors |
19.08.2015 | - | $3M | - |
Mentions in press and media 11
Date | Title | Description | Source |
13.12.2018 | How traditional pharmacies can survive the Amazon threat | Are traditional pharmacies doomed to the same fate as Borders, Blockbuster, and Sears? The threat is... | statnews.c... |
02.04.2018 | Adherium gets FDA clearance for OTC sales of sensor to suppo... | The sensor attaches to the user’s inhaler and tracks their daily usage. The company’s sensor records... | medcitynew... |
25.01.2018 | New Zealand remote monitoring tech for COPD, asthma opens U.... | In an interview, CEO Arik Anderson told MobiHealthNews that SmartTouch is keen to work with insuranc... | medcitynew... |
01.09.2017 | In collaboration with AstraZeneca, Adherium CEO shares evolu... | “Initially we were looking at stand alone inhaler devices with sensors able to detect when the devic... | medcitynew... |
20.07.2016 | Smart inhaler company Adherium raises $5.9M from Fidelity | Adherium, a Melbourne, Australia-based connected inhaler company, has raised $5.9 million ($8 millio... | mobihealth... |
03.12.2015 | 5 digital health tools that could improve COPD management | LifeMap Solutions has launched its COPD Navigator app for iOS devices. It was developed through a pa... | medcitynew... |
19.08.2015 | AstraZeneca invests $3M in NZ smart inhaler maker Adherium | Adherium Limited, a New Zealand company working on a smart inhaler, has raised $25.6 million ($35 mi... | mobihealth... |
- | New Zealand remote monitoring tech for COPD, asthma opens U.... | Four months after Adherium secured FDA clearance for an inhaler sensor called SmartTouch for use wit... | medcitynew... |
- | 5 digital health tools that could improve COPD management | This post has been updated from an earlier version to reflect comments from LifeMap Solutions CEO Co... | medcitynew... |
- | Adherium gets FDA clearance for OTC sales of sensor to suppo... | SmartTouch for AstraZeneca’s Symbicort inhaler New Zealand device developer Adherium has secured FD... | medcitynew... |
Show more